Call for Grant Applications -Bridging Narratives Grant Program
About Organisation
Cure Parkinson’s is a leading organization dedicated to funding innovative research aimed at slowing, stopping, or reversing Parkinson’s disease. The organization focuses on identifying and supporting groundbreaking scientific studies that have the potential to transform the treatment landscape for Parkinson’s. By fostering collaboration between researchers, clinicians, and commercial entities, Cure Parkinson’s plays a crucial role in accelerating progress toward effective therapies. The organization prioritizes research with a strong translational impact, ensuring that promising discoveries move quickly from the lab to clinical trials and ultimately benefit patients. Their commitment extends beyond funding, as they actively engage with the global research community to support the development of treatments that address the root causes of Parkinson’s. Through its rigorous grant selection process, Cure Parkinson’s ensures that only the most impactful and scientifically sound projects receive support. Their Quarterly Research Grant Programme is an integral part of this mission, providing researchers with essential funding to explore novel approaches and innovative treatments. With a dedicated independent research committee evaluating proposals, Cure Parkinson’s maintains a high standard for the studies it funds, ensuring that every investment aligns with its goal of advancing Parkinson’s research and improving the lives of those affected by the disease.
About the Grant
The Cure Parkinson’s Quarterly Research Grant Funding Programme is designed to support preclinical and clinical research that aims to slow, halt, or reverse the progression of Parkinson’s disease. The funding programme prioritizes projects that have strong potential to transition into clinical trials within five years, ensuring that scientific breakthroughs translate into tangible patient benefits. The grant operates on a quarterly basis, allowing researchers to submit proposals throughout the year for consideration. Successful applications undergo a rigorous two-stage review process conducted by an independent research committee. This ensures that only high-quality, impactful studies receive funding. Preclinical research projects are eligible for funding up to £250,000 (GBP), with a focus on accelerating their progression toward clinical trials. Projects that align with Cure Parkinson’s mission and demonstrate a clear pathway toward meaningful therapeutic advancements are given priority. The entire evaluation process typically takes around three months but may take longer for clinical trials requiring iterative reviews. Cure Parkinson’s is committed to supporting research that brings the world closer to effective treatments, providing scientists with the resources necessary to drive innovation in Parkinson’s disease research and treatment development.
Who can Apply?
The Cure Parkinson’s Quarterly Research Grant Programme is open to a diverse range of applicants, including academic researchers and commercial entities dedicated to Parkinson’s research. This inclusivity allows for a broad spectrum of innovative ideas and collaborative efforts, increasing the chances of groundbreaking discoveries. Researchers from universities, medical institutions, and research organizations are encouraged to apply, particularly those working on translational research that can be rapidly moved into clinical applications. The funding programme seeks projects that align with Cure Parkinson’s mission to develop therapies that slow, stop, or reverse Parkinson’s disease. Priority is given to studies with a clear pathway to clinical trials within five years, ensuring practical applicability and patient impact. Applications are reviewed based on scientific rigor, feasibility, and potential therapeutic significance. Commercial entities engaged in Parkinson’s research can also apply, provided their proposals demonstrate a significant contribution to advancing treatments. The selection process involves a thorough review by Cure Parkinson’s independent research committee, which evaluates each project’s potential before making funding recommendations. By welcoming applications from both academic and commercial sectors, Cure Parkinson’s fosters innovation and accelerates the development of effective treatments for Parkinson’s disease.
How to Apply?
Interested applicants must submit a Stage 1 Application, which will be reviewed by Cure Parkinson’s independent research committee. If selected, they will be invited to submit a full proposal (Stage 2), which undergoes external peer review. Successful applicants receive funding recommendations for approval.
Application Deadline
The Quarterly Research Grant Programme operates on a rolling basis, with applications reviewed every three months. The next deadline for submissions is 5 May 2025.
Last Date to Apply
All applications must be submitted before 5 May 2025 to be considered in the upcoming funding cycle.
Grant Amount
For preclinical research, grants are available up to £250,000 (GBP), with priority given to projects that can transition to clinical trials within five years.
Last Date To Apply
For more information, please visit the grant website here.
